ACD RNAscope® Seminar Series
University of Minnesota 
Moos Tower Room 2-580
Minneapolis, MN
 
Monday, August 8, 2:00 pm – 3:30 pm

You are invited!

Current State-of-the-Art in Tissue-base RNA Analysis with RNAscope® Technology

 
Advanced Cell Diagnostics’ RNAscope® platform is fast becoming a routinely used method for gene expression analysis. ACD has nearly 9000 RNA-specific target probes and over 500 publications using this method. RNAscope® is enabling faster and more rigorous biomarker analysis; it is a robust and ultra-sensitive RNA in situ hybridization method providing single-cell and single-molecule RNA detection in the morphological context of disease micro-environments. Using our proprietary oligo probe design and amplification methods, RNAscope® technology's detection limit is significantly lower than IHC and has been clinically validated; it has enabled patient selection in clinical trials and ACD has partners for CDx development. The technology and illustrations of published application will be presented.

 

University of Minnesota Seminar 

Moos Tower Room 2-580

Monday August 8, 2:00 pm–3:30 pm 

AGENDA:

 

2:00 pm–2:45 pm
Speaker: Emily Park, Ph.D
Senior Director Application Development, Advanced Cell Diagnostics
Current state-of-the-art tissue-based RNA analysis with RNAscope® technology

 

2:45 pm–3:15 pm
Speaker: Fabio Vannucci, Ph.D
Assistant Professor, University of Minnesota
The use of RNAScope for rapid diagnostic response to emerging and endemic diseases in large animals.

 

3:15 pm–3:30 pm

Q&A session

RNA expression of EPCAM1 (red dots) and EGFR (green dots)  is breast cancer FFPE tissue using RNAscope® Duplex Assay


Wnt4 RNA expression (brown dots) in mouse eye FFPE Tissue using RNAscope® Assay v2.5 Brown


Npy(green dots) & Fexf2 (red)  RNA expression in mouse brain fresh frozen tissue; RNAscope® Multiplex Fluorescent Assay